Parameter
| Biomarker | HDL-C | Full name | High density lipoprotein cholesterol | Molecular Type | Lipids |
|---|---|---|---|---|---|
| Molecular Formula | C₂₇H₄₆O | Molecular Weight | 386.65 | Core Functional Dimensions | Diagnosis and Prognosis |
| Disease | Metabolic Syndrome | Disease Subtypes | / | ||
| Organ | Liver/Blood Vessels | Test Sample / Technology Platform | Serum/plasma (enzymatic, ultracentrifugation) | ||
| Pathobiological Mechanisms | The function of reverse cholesterol transport is impaired, and the anti-inflammatory and antioxidant effects are weakened | ||||
| Clinical Availability Status | Clinical routine application: diagnostic core indicators | ||||
| Notes and Dynamics | Decreased HDL-C is positively associated with the risk of cardiovascular complications | ||||